Severe kaliopenia and electrolytic gradient disturbances in medico-surgical resuscitation. Value of a spironolactone with antialdosterone and catatoxic effect
Larcan, A.; Calamai, M.; Jacob, F.
Agressologie Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 12(3): 223-232
1971
ISSN/ISBN: 0002-1148 PMID: 5122615 Document Number: 42745
Document emailed within 1 workday
Related Documents
Roquefeuil, B.; Nord, D.; Viguie, E.; Fischbach, C. 1972: Modification of ionic balance by an injectable antialdosterone drug in resuscitation Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 13(3): 185-194Ruta, J.; Ptaszyński, Pł.; Maciejewski, M.; Chizyński, K.; Goch, J.Henryk. 2006: Effect of spironolactone on mortality in patients with severe left ventricular dysfunction after acute myocardial infarction Przeglad Lekarski 63(12): 1249-1251
Okumura, H.; Aramaki, T.; Katsuta, Y.; Satomura, K.; Akaike, M.; Sekiyama, T.; Terada, H.; Ohsuga, M.; Komeichi, H.; Tsutsui, H. 1991: Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites American Journal of Gastroenterology 86(1): 46-52
Stoll, W. 1979: Medico-legal assessment of vestibular disturbances Laryngologie Rhinologie Otologie 58(6): 509-515
Markov, K.M.; Ivanova, I.A.; Bankova, V.V.; Mikhalkina, V.G. 1973: Effect of antialdosterone preparation veroshpiron on the development of hypertension and the activity of adrenal cortex in rats Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 17(6): 23-26
Bevilacqua, C. 1970: Medico-legal problems related to resuscitation methods Acta Anaesthesiologica 21(1): 95-105
Bauer, M.; Feucht, K.; Ziegenfuss, T.; Marzi, I. 1995: Attenuation of shock-induced hepatic microcirculatory disturbances by the use of a starch-deferoxamine conjugate for resuscitation Critical Care Medicine 23(2): 316-322
Skvortsov, A.A.; Mareev, V.Y.; Chelmakina, S.M.; Baklanova, N.A.; Belenkov, I.N. 2007: Efficacy and safety of long-term application of spironolactone in patients with moderate and severe chronic heart failure receiving optimal therapy Kardiologiia 47(10): 12-23
Plouin, P.-F.ço. 2013: Medico social management of severe hypertension La Revue du Praticien 63(5): 684-685
Stripp, B.; Taylor, A.A.; Bartter, F.C.; Gillette, J.R.; Loriaux, D.L.; Easley, R.; Menard, R.H. 1975: Effect of spironolactone on sex hormones in man Journal of Clinical Endocrinology and Metabolism 41(4): 777-781
Coksevim, B.; Tayyar, M. 1994: The effect of spironolactone on the rat uterus Journal of the Medical Association of Thailand 77(10): 539-543
Selye, H. 1970: The catatoxic steroids Giornale di Clinica Medica 51(8): 620-623
Káldor, A.; Kállay, K.; Sebestyén, K.; Alexits, K. 1972: The effect of alpha methyldopa and spironolactone on angiotensin sensitivity in man Orvosi Hetilap 113(1): 23-24
Zlatin, R.S.; Plesskaia, T.N. 1977: Effect of electric stimulation and electrolytic destruction of posterior hypothalamic structures on the electrical activity of the motor area of the rabbit cortex Fiziolohichnyi Zhurnal 23(1): 39-45
Lichey, J.; Schröder, R.; Rietbrock, N. 1977: The effect of oral spironolactone and intravenous canrenoate-K on the digoxin radioimmunoassay International Journal of Clinical Pharmacology and Biopharmacy 15(12): 557-559
Kourounakis, P.N.; Rekka, E. 1994: Effect of spironolactone on dimethyl mercury toxicity. A possible molecular mechanism Arzneimittel-Forschung 44(10): 1150-1153
Widimský, Jří. 2015: PATHWAY-2 Study: spironolactone vs placebo, bisoprolol and doxazosin to determine optimal treatment of resistant hypertension. Spironolactone high effective in lowering blood pressure in drug resistant hypertension Vnitrni Lekarstvi 61(12): 1067-1071
Krysiak, R.; Marek, B.; Okopień, B.ła. 2009: Inhibitory effect of carbamazepine on hypotensive action of spironolactone in primary aldosteronism Endokrynologia Polska 60(1): 52-55
Bordás, E.; Bretter, E.; Uray, Z. 1981: Effect of spironolactone (Aldactone-A) on the function of the thyroid gland in white rats Endocrinologie 19(1): 33-37
Miguet, J.P.; Mavier, P.; Arondel, J.; Preaux, A.M.; Dhumeaux, D. 1977: Effect of spironolactone on bile formation and liver microsomal enzymic activities in the rat Gastroenterologie Clinique et Biologique 1(12): 1007-1013